GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dishman Carbogen Amics Ltd (NSE:DCAL) » Definitions » Gross Profit

Dishman Carbogen Amics (NSE:DCAL) Gross Profit : ₹20,186 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Dishman Carbogen Amics Gross Profit?

Dishman Carbogen Amics's gross profit for the three months ended in Mar. 2024 was ₹4,733 Mil. Dishman Carbogen Amics's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₹20,186 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Dishman Carbogen Amics's gross profit for the three months ended in Mar. 2024 was ₹4,733 Mil. Dishman Carbogen Amics's Revenue for the three months ended in Mar. 2024 was ₹6,547 Mil. Therefore, Dishman Carbogen Amics's Gross Margin % for the quarter that ended in Mar. 2024 was 72.29%.

Dishman Carbogen Amics had a gross margin of 72.29% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Dishman Carbogen Amics was 80.30%. The lowest was 65.13%. And the median was 78.45%.


Dishman Carbogen Amics Gross Profit Historical Data

The historical data trend for Dishman Carbogen Amics's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dishman Carbogen Amics Gross Profit Chart

Dishman Carbogen Amics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,679.90 14,279.40 16,818.00 18,961.00 20,185.80

Dishman Carbogen Amics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,337.50 5,600.70 4,522.40 5,329.70 4,733.00

Competitive Comparison of Dishman Carbogen Amics's Gross Profit

For the Biotechnology subindustry, Dishman Carbogen Amics's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dishman Carbogen Amics's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Gross Profit distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's Gross Profit falls into.



Dishman Carbogen Amics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Dishman Carbogen Amics's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=26157.7 - 5971.9
=20,186

Dishman Carbogen Amics's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=6547.1 - 1814.1
=4,733

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹20,186 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Dishman Carbogen Amics's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=4,733 / 6547.1
=72.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Dishman Carbogen Amics  (NSE:DCAL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Dishman Carbogen Amics had a gross margin of 72.29% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Dishman Carbogen Amics Gross Profit Related Terms

Thank you for viewing the detailed overview of Dishman Carbogen Amics's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Dishman Carbogen Amics (NSE:DCAL) Business Description

Traded in Other Exchanges
Address
Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.

Dishman Carbogen Amics (NSE:DCAL) Headlines

No Headlines